AN2 Therapeutics Inc./$ANTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
Ticker
$ANTX
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
22
ISIN
US0373261058
Website
ANTX Metrics
BasicAdvanced
$33M
-
-$1.52
0.01
-
Price and volume
Market cap
$33M
Beta
0.01
52-week high
$1.55
52-week low
$1.01
Average daily volume
244K
Financial strength
Current ratio
8.68
Quick ratio
8.405
Management effectiveness
Return on assets (TTM)
-29.49%
Return on equity (TTM)
-49.32%
Valuation
Price to book
0.46
Price to tangible book (TTM)
0.46
Price to free cash flow (TTM)
-0.785
Growth
Earnings per share change (TTM)
-39.82%
3-year earnings per share growth (CAGR)
-50.49%
ANTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AN2 Therapeutics Inc. stock?
AN2 Therapeutics Inc. (ANTX) has a market cap of $33M as of June 06, 2025.
What is the P/E ratio for AN2 Therapeutics Inc. stock?
The price to earnings (P/E) ratio for AN2 Therapeutics Inc. (ANTX) stock is 0 as of June 06, 2025.
Does AN2 Therapeutics Inc. stock pay dividends?
No, AN2 Therapeutics Inc. (ANTX) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next AN2 Therapeutics Inc. dividend payment date?
AN2 Therapeutics Inc. (ANTX) stock does not pay dividends to its shareholders.
What is the beta indicator for AN2 Therapeutics Inc.?
AN2 Therapeutics Inc. (ANTX) has a beta rating of 0.01. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.